| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | TETRAPHASE PHARMACEUTICALS INC COM | 81,185 | 606,000 | 0.02% | ||
| 102 | PTC THERAPEUTICS INC | 23,387 | 624,000 | 0.03% | ||
| 103 | COLLABRX INC | 920,375 | 635,000 | 0.03% | ||
| 104 | ZOSANO PHARMA CORP | 163,365 | 647,000 | 0.03% | ||
| 105 | DBV TECHNOLOGIES S A | 18,541 | 660,000 | 0.03% | ||
| 106 | VIGGLE INC | 812,687 | 666,000 | 0.03% | ||
| 107 | TRANSITION THERAPEUTICS INC | 382,600 | 685,000 | 0.03% | ||
| 108 | EYEGATE PHARMACEUTICALS INC COM | 243,790 | 695,000 | 0.03% | ||
| 109 | SUNEDISON INC | 1,000 | 718,000 | 0.03% | Call | |
| 110 | STRATA SKIN SCIENCES INC COM | 657,860 | 750,000 | 0.03% | ||
| 111 | Cellectar Biosciences @4.68 8/ | 381,172 | 751,000 | 0.03% | ||
| 112 | BELLICUM PHARMACEUTICALS INC | 526 | 764,000 | 0.03% | Call | |
| 113 | NEUROMETRIX INC | 873,454 | 771,000 | 0.03% | ||
| 114 | ZS PHARMA INC | 11,875 | 780,000 | 0.03% | ||
| 115 | CYTOKINETICS INC | 1,176 | 787,000 | 0.03% | Put | |
| 116 | Aldeyra Therapeutics Inc | 134,997 | 787,000 | 0.03% | ||
| 117 | TESARO INCORPORATED | 20,000 | 802,000 | 0.03% | ||
| 118 | TESARO INC | 200 | 802,000 | 0.03% | Put | |
| 119 | RADIUS HEALTH INCORPORATED COM NEW | 11,600 | 804,000 | 0.03% | ||
| 120 | EDAP TMS SA | 1,466 | 819,000 | 0.03% | Put | |
| 121 | MOMENTA PHARMACEUTICALS INC | 50,030 | 821,000 | 0.03% | ||
| 122 | TONIX PHARMACEUTICALS HOLDING | 158,140 | 837,000 | 0.03% | ||
| 123 | CTI BIOPHARMA CORP | 5,747 | 839,000 | 0.03% | Call | |
| 124 | AQUINOX PHARMACEUTICALS INC | 60,000 | 844,000 | 0.03% | ||
| 125 | CYNAPSUS THERAPEUTICS INC | 52,169 | 845,000 | 0.03% | ||
| 126 | SYNERGY PHARMACEUTICALS DEL | 1,613 | 855,000 | 0.04% | Put | |
| 127 | STEMCELLS INC COM NEW | 2,039,122 | 856,000 | 0.04% | ||
| 128 | IDERA PHARMACEUTICALS INC | 2,558 | 857,000 | 0.04% | Call | |
| 129 | TONIX PHARMACEUTICALS HLDG C | 1,631 | 863,000 | 0.04% | Call | |
| 130 | ADVAXIS INC | 852 | 872,000 | 0.04% | Put | |
| 131 | ADVAXIS INC COM NEW | 85,700 | 877,000 | 0.04% | ||
| 132 | PORTOLA PHARMACEUTICALS INC | 206 | 878,000 | 0.04% | Put | |
| 133 | CHAMPIONS ONCOLOGY INC | 169,397 | 893,000 | 0.04% | ||
| 134 | GW PHARMACEUTICALS PLC | 100 | 914,000 | 0.04% | Call | |
| 135 | Heartware International, Inc. | 17,500 | 915,000 | 0.04% | ||
| 136 | Natera, Inc. | 86,523 | 939,000 | 0.04% | ||
| 137 | NEVRO CORP | 203 | 942,000 | 0.04% | Call | |
| 138 | Anacor Pharmaceuticals Inc | 8,000 | 942,000 | 0.04% | ||
| 139 | DEPOMED INC | 50,000 | 943,000 | 0.04% | ||
| 140 | ZAFGEN INC | 296 | 946,000 | 0.04% | Put | |
| 141 | INSMED INC | 511 | 949,000 | 0.04% | Call | |
| 142 | BIOCRYST PHARMACEUTICALS | 86,395 | 985,000 | 0.04% | ||
| 143 | ARIAD PHARMACEUTICALS ORD (NMS) | 169,000 | 987,000 | 0.04% | ||
| 144 | ARIAD PHARMACEUTICALS INC | 1,690 | 987,000 | 0.04% | Put | |
| 145 | CYTORI THERAPEUTIC INC | 2,941,880 | 1,000,000 | 0.04% | ||
| 146 | EXELIXIS INC | 1,783 | 1,000,000 | 0.04% | Call | |
| 147 | CAPRICOR THERAPEUTICS INC | 250,450 | 1,014,000 | 0.04% | ||
| 148 | AMICUS THERAPEUTICS INC | 730 | 1,021,000 | 0.04% | Call | |
| 149 | INOTEK PHARMACEUTICALS CORP | 110,000 | 1,034,000 | 0.04% | ||
| 150 | INTREXON CORP | 325 | 1,034,000 | 0.04% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-065626, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
